a.kwiatkowski

TL2 Member · Valencia, ES

Keeps a personal log and shares the numbers when they are relevant, with the measurement caveats attached.

Joined 30 July 2025 · last posted 13h

84 posts, newest first. Showing up to 150.

Rewriting my first post: a before-and-after, with commentary — what changed since Replied, post #20 · Start Here › How to Ask · 27 Jul 2026 · 0 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is…
Second pass at: When your prescriber and the evidence disagree Replied, post #55 · Clinical › Prescriber conversations · 24 Jul 2026 · 3 likes Confirming post #52 from a second method, which matters more than confirming it from a second person. Adding a null result on prescriber. I looked, carefully, and found…
GLP-1 receptor distribution: central and peripheral Replied, post #96 · Pharmacology › Receptor biology · 23 Jul 2026 · 16 likes Right — I had this wrong and I am glad to have read it before it mattered.
An 18-month record including the parts that went badly Replied, post #72 · Outcomes › Progress reports · 17 Jul 2026 · 8 likes Two sentences on 18-month record and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is…
Private prescribing in the UK: what is actually involved Replied, post #67 · Regional › UK & Ireland · 17 Jul 2026 · 20 likes Post #64 answers the question as asked. The question underneath it is different. Reading back through the private prescribing threads from last year, the same three…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #44 · Analytics › Method validation · 16 Jul 2026 · 0 likes Narrowing post #43, because the general version has more than one answer. Having read the whole specificity thread before replying: the question in the first post has…
Revisiting: Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #4 · Compounds › Retatrutide · 15 Jul 2026 · 2 likes The arithmetic in the opening post is right; the assumption feeding it is the part to check. If you are new and reading this thread for the answer to Hepatic effects of…
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #49 · Practice › Side effects · 14 Jul 2026 · 5 likes Post #47 answers the question as asked. The question underneath it is different. Constipation is reported at least as often as nausea and is discussed a fraction as…
Follow-up: Reading an interaction checker output critically Replied, post #37 · Practice › Interactions · 8 Jul 2026 · 24 likes Post #34 is the version of this I will quote in future. One addition. Renal or hepatic impairment changes the calculus for a lot of combinations and is the context most…
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #40 · Documentation › Doc review · 7 Jul 2026 · 0 likes Objections are genuinely wanted at this stage, because a bad promotion is much harder to undo than a bad reply. The reasoning is more useful than the number, which is…
NHS criteria and how they are applied in practice Replied, post #13 · Regional › UK & Ireland · 27 Jun 2026 · 3 likes Agreed on all of that, and I have nothing to add to it.
Aggregate verification data across the directory, with caveats Replied, post #15 · Sourcing › Independent verification · 27 Jun 2026 · 1 like Aggregate verification data is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
Coming back to: Where the four-week escalation interval comes from, and what it is not Started this topic · Practice › Dosing & titration · 24 Jun 2026 · 0 likes Posting this under the heading it deserves: Where the four-week escalation interval comes from, and what it is not Everything below is what sits behind that. Four-week…
Batch numbers that do not match the vial label — what changed since Replied, post #37 · Sourcing › Red flags · 14 Jun 2026 · 24 likes Reporting something here requires the batch, the date, the method and the document, which is exactly what makes the reports worth reading two years later.
Endotoxin and why it is a separate question from purity — what changed since Replied, post #44 · Analytics › Impurities & related substances · 12 Jun 2026 · 21 likes Noted, and I have changed what I was going to do on the strength of it.
Micronutrient adequacy at low total intake Replied, post #63 · Nutrition & Training › Protein & intake · 11 Jun 2026 · 16 likes On post #60 — agreed on the reasoning, with one qualification. Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the…
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #40 · Practice › Administration · 11 Jun 2026 · 7 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
CJC-1295 with and without DAC: what the modification does Replied, post #80 · Compounds › Secretagogues & GH axis · 10 Jun 2026 · 4 likes What I want from this CJC-1295 thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
The anatomy of a question that gets answered within an hour Replied, post #70 · Start Here › How to Ask · 7 Jun 2026 · 3 likes That is clearer than the version I had in my head. Thank you.
Prescription portability between countries Replied, post #52 · Access › International · 3 Jun 2026 · 0 likes The reason prescription portability between countries is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and…
Why the cheapest option is often not the cheapest Replied, post #6 · Access › Pricing · 2 Jun 2026 · 0 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
Peak-to-trough ratio at steady state for a weekly agent Replied, post #39 · Pharmacology › Pharmacokinetics · 2 Jun 2026 · 0 likes Where I part company with post #37, and it is a narrow parting. Peak-to-trough ratio looks different depending on whether you are reading the primary literature or the…
Reading a trial's population section before its results Replied, post #24 · Evidence › Trials · 15 May 2026 · 1 like Worth separating two things that post #22 runs together. Confounding in observational data: a third variable can explain an apparent association. In a randomised trial,…
What to include when your question involves a chromatogram — one year on Replied, post #6 · Start Here › How to Ask · 15 May 2026 · 0 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. A qualification I should have led with…
Request: show the solution author in the topic list — what changed since Replied, post #89 · Meta › Feature requests · 4 May 2026 · 4 likes Feature request I expect to be refused, stated anyway: a private notes field on a topic, visible only to me. I keep those in a text file and the text file loses the…
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #71 · Evidence › Trials · 3 May 2026 · 1 like Filing a mild objection to the consensus on Subgroup analyses. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
Tracking intake honestly when appetite is absent Replied, post #11 · Nutrition & Training › Protein & intake · 29 Apr 2026 · 0 likes Post #7 put the caveat in the right place and I want to underline it. Nobody has said the unglamorous part of tracking intake yet, so: most of the variation is…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #44 · Evidence › Journal club · 21 Apr 2026 · 29 likes On orforglipron phase 2 I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how…
Sample size intuition for a personal experiment — does this still hold? Replied, post #16 · Research Methods › Statistics · 17 Apr 2026 · 24 likes Where I part company with post #12, and it is a narrow parting. Effect size with an interval is more informative than a significance verdict in essentially every case…
List price versus negotiated price versus what you pay Replied, post #77 · Access › Pricing · 14 Apr 2026 · 0 likes Post #73 describes the usual case. This is about the unusual one. On list price versus negotiated price: the maintained page in the documentation commons covers the…
Fasting versus non-fasting and which tests care Replied, post #11 · Clinical › Bloodwork · 12 Apr 2026 · 6 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line. Written from notes rather than memory, which is why…
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #38 · Start Here › Welcome · 9 Apr 2026 · 17 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Why retatrutide discussion here is more cautious than elsewhere Replied, post #3 · Compounds › Retatrutide · 22 Mar 2026 · 0 likes Answering the question the opening post raises rather than the one it answers. Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not…
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #69 · Practice › Interactions · 16 Mar 2026 · 7 likes Building on post #66 rather than restating it. Marking my uncertainty on Common supplements explicitly. I am confident about the direction, much less confident about…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #116 · Access › Pricing · 15 Mar 2026 · 21 likes Bookmarking this. I will come back when I have something worth adding.
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #21 · Compounds › Cagrilintide & amylin analogues · 22 Feb 2026 · 15 likes Research-use-only cagrilintide is not approved for human use and the published evidence base is a clinical-trial evidence base. Those two facts sit uncomfortably…
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #19 · Practice › Administration · 13 Feb 2026 · 29 likes I have no financial interest in anything named in this thread and I want to say so before I comment on Pinch, because it is the sort of subject where it matters.
Angle of injection and whether 90 degrees is always right Replied, post #96 · Practice › Administration · 7 Feb 2026 · 27 likes Right, and stated more narrowly than I would have dared to state it.
Storing lyophilised material long term: what governs the shelf life Replied, post #46 · Practice › Storage & stability · 31 Jan 2026 · 13 likes Answering the question post #44 raises rather than the one it answers. Genuine question rather than a rhetorical one: has anyone here actually observed storing…
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Replied, post #9 · Compounds › Secretagogues & GH axis · 20 Jan 2026 · 0 likes Post #7 is right about the mechanism and I think understates the practical bit. Reconstitution volumes in this family are often small enough that dead volume in the…
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #8 · marked as the solution · Analytics › Mass spectrometry · 13 Jan 2026 · 22 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
Aggregates and why a purity assay may miss them entirely Replied, post #58 · Analytics › Impurities & related substances · 8 Jan 2026 · 1 like Saving this. It is the version I will quote when the question comes round again.
Personal import allowances, compared Replied, post #4 · Access › International · 18 Dec 2025 · 23 likes Coming back to the opening post, because the follow-up matters more than the original answer. Nothing here is legal advice, and in this subcategory that caveat is doing…
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #47 · Sourcing › Vendor reports · 18 Dec 2025 · 0 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere.
The decimal-point error, and the habit that catches it Replied, post #98 · Practice › Reconstitution · 18 Dec 2025 · 0 likes Two claims get bundled together under decimal-point error and they need separating. The descriptive one — this is what was observed — is usually well supported. The…
A history of disordered eating: proceeding carefully Replied, post #15 · Wellbeing › Mental health · 29 Nov 2025 · 22 likes Post #13 answers the question as asked. The question underneath it is different. Counterpoint on history of disordered eating, offered without confidence: the same…
How to ask about something you suspect is a bad idea Replied, post #29 · Start Here › How to Ask · 28 Nov 2025 · 0 likes I read post #27 twice before replying, because I had assumed the opposite. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the…
Managing an unplanned gap in supply — what changed since Replied, post #125 · Access › Shortages · 24 Nov 2025 · 0 likes Worth separating two things that post #121 runs together. Where a manufacturer publishes a supply statement, that document is more reliable than any aggregation of…
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #46 · Wellbeing › Mental health · 5 Nov 2025 · 5 likes Picking up post #44: that is the part I would want checked first. The documentation on Anxiety is better than this thread and I say that as someone who has posted in…
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #23 · Analytics › Method validation · 2 Nov 2025 · 0 likes A method that reports the same number for every lot is worth a second look. Real processes vary, and a total absence of variation is a statement about the measurement…
New subcategory: rationale and scope Replied, post #131 · Meta › Announcements · 26 Oct 2025 · 23 likes Adding the measurement that post #128 says would settle it. Whatever the answer on new subcategory turns out to be, the method for getting there is the same: state the…
Payment mechanics and the recovery options that do not exist Replied, post #67 · Sourcing › Payments · 21 Oct 2025 · 1 like Ask what happens if the material fails independent testing before you order, not afterwards. The answer is informative and costs one email.
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #49 · Compounds › Cagrilintide & amylin analogues · 3 Oct 2025 · 16 likes Answering the question post #45 raises rather than the one it answers. Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The…
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #94 · Evidence › Preprints · 3 Oct 2025 · 0 likes On post #90 — agreed on the reasoning, with one qualification. Where a preprint contradicts a published trial, the prior should favour the trial. Where it extends one,…
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #27 · Clinical › Special populations · 26 Sep 2025 · 2 likes Dedicated trials in under-studied populations are the only real remedy and several are ongoing, which is worth saying rather than speculating.
Persistent vomiting and the threshold for seeking help Replied, post #37 · Safety › Adverse events · 20 Sep 2025 · 9 likes If someone has run persistent vomiting properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
Tracking that stops updating and then resumes Replied, post #23 · Sourcing › Logistics · 2 Sep 2025 · 13 likes Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you are protecting against.
How to research a compound with no human data without deceiving yourself Replied, post #24 · Compounds › Other compounds · 31 Jul 2025 · 23 likes Coming back to post #22, because the follow-up matters more than the original answer. How to research a compound with no human data: mechanistic plausibility is one…
What a documentation review can and cannot tell you Replied, post #42 · Sourcing › Independent verification · 21 Jul 2025 · 0 likes What I want from this documentation review thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #164 · Practice › Reconstitution · 14 Jul 2025 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #9 · Pharmacology › Receptor biology · 22 Jun 2025 · 28 likes That reframing is the whole thing. The facts I already had.
System suitability injections: if they failed, the run did not happen Replied, post #6 · Analytics › HPLC & UHPLC · 9 Jun 2025 · 19 likes Post #3 and I disagree about the size of the effect, not about the direction. I would be cautious about generalising from the system suitability injections example…
Asking about a compound your prescriber has not heard of Replied, post #56 · Clinical › Prescriber conversations · 3 Jun 2025 · 0 likes A pharmacist can answer a great many of the questions people save for a prescriber, faster and often better, particularly about interactions and formulations. I would…
Pre-registering a personal experiment, seriously Replied, post #43 · Research Methods › N-of-1 designs · 29 May 2025 · 0 likes Speaking only to pre-registering a personal experiment as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the…
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #53 · Compounds › Retatrutide · 27 May 2025 · 0 likes Post #52 is the version of this I will quote in future. One addition. Distinguishing three things in the Retatrutide mass and identity discussion that keep getting used…
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #2 · Analytics › Method validation · 22 May 2025 · 12 likes Validation is compound-specific and matrix-specific. A method validated for one peptide is a starting point for another and not a validated method for it.
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #129 · Sourcing › Independent verification · 21 May 2025 · 0 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want. Take the…
Distinguishing a deletion sequence by mass alone — the long version Replied, post #19 · Analytics › Mass spectrometry · 8 May 2025 · 0 likes Noted, and I have changed what I was going to do on the strength of it.
Adjudicated events and why the definition matters — the long version Replied, post #131 · Evidence › Trials · 2 May 2025 · 2 likes Coming back to post #127, because the follow-up matters more than the original answer. Adjudicated events came up in a thread eighteen months ago and was answered well.…
An emergency department visit, described afterwards Replied, post #14 · Safety › Adverse events · 24 Apr 2025 · 9 likes On post #13 — agreed on the reasoning, with one qualification. An honest declaration on emergency department visit: I have a prior here and it is strong enough that you…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #55 · Evidence › Journal club · 19 Apr 2025 · 12 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #18 · Compounds › Oral incretins · 14 Apr 2025 · 0 likes The arithmetic in post #15 is right; the assumption feeding it is the part to check. The thirty-minute wait before eating is not conservatism. Food in the stomach…
Coming back to: Sample size calculations, read backwards from the published number Replied, post #8 · Evidence › Trials · 2 Apr 2025 · 2 likes Agreed, and I will stop repeating the version of this I had been repeating.
Telehealth prescribing models in the US Replied, post #71 · Regional › North America · 16 Mar 2025 · 6 likes This follows post #68 rather than contradicting it. I have three months of notes on telehealth prescribing models and the honest summary is that the trend is real and…
Biased agonism: a real phenomenon, an over-used explanation Replied, post #54 · Pharmacology › Receptor biology · 7 Mar 2025 · 5 likes Glucagon receptor agonism raises energy expenditure and promotes hepatic fat oxidation. In a triple agonist the incretin limbs offset the glycaemic consequence, which…
Counter-ion form: the field almost nobody reports — one year on Replied, post #27 · Analytics › COA interpretation · 25 Feb 2025 · 14 likes The useful distinction on Counter-ion form is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error…
Fixed versus detachable needles: the trade-offs Replied, post #111 · Devices › Syringes & needles · 14 Jan 2025 · 0 likes U-100 means the barrel is graduated for a solution containing one hundred units of insulin per millilitre. For anything that is not insulin, the units are simply…
Why "any advice?" is the least effective ending for a post Replied, post #80 · Start Here › How to Ask · 27 Nov 2024 · 32 likes I read post #77 twice before replying, because I had assumed the opposite. Context that matters: compound, how long in, current dose, relevant history. Context that…
Food noise reducing and the disorientation that can follow Replied, post #41 · Wellbeing › Mental health · 15 Nov 2024 · 4 likes That is a fair summary of where the discussion has got to.
Transit times by route, from a logged dataset — the long version Replied, post #25 · Sourcing › Logistics · 31 Oct 2024 · 23 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing. I would want to see it done twice…
Meeting a protein target on a suppressed appetite — one year on Started this topic · Nutrition & Training › Protein & intake · 30 Aug 2024 · 16 likes Meeting a protein target on a suppressed appetite — one year on — setting out what I have, and where I think it stops being reliable. Asking about Meeting a protein…
Correlation in a self-tracked dataset: what it can support Replied, post #166 · Research Methods › Statistics · 26 Aug 2024 · 0 likes Number needed to treat: how many people need to be treated to prevent one bad outcome or achieve one good outcome. More intuitive than relative risk reduction. Posting…
Reporting a discrepancy without making an allegation Replied, post #23 · Sourcing › Vendor reports · 11 Aug 2024 · 17 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
Coming back to: Grapefruit: why this class is not the class that cares Started this topic · Practice › Interactions · 9 Aug 2024 · 42 likes Posting this under the heading it deserves: Grapefruit: why this class is not the class that cares Everything below is what sits behind that. I was wrong about…